Compugen (CGEN) News Today $1.94 -0.02 (-1.02%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$1.96 +0.03 (+1.29%) As of 10/23/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Compugen Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done Compugen (NASDAQ:CGEN) & Co-Diagnostics (NASDAQ:CODX) Critical ContrastOctober 23 at 3:59 AM | americanbankingnews.comCompugen Ltd. (NASDAQ:CGEN) Stock Has Consensus Price Target of $5.00October 18, 2026 | marketbeat.comCompugen (NASDAQ:CGEN) Stock Rating Reaffirmed as Buy by HC WainwrightOctober 12, 2026 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK) and Compugen (CGEN)October 7, 2026 | theglobeandmail.comStifel Nicolaus Remains a Buy on Compugen (CGEN)October 7, 2026 | theglobeandmail.comCompugen to Participate in a Fireside Chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development ConferenceOctober 6, 2026 | prnewswire.comCompugen Highlights COM701 Ovarian Trial, Expands AI Platform Into Tumor TargetsOctober 5, 2026 | marketbeat.comCompugen Ltd. (CGEN) Discusses COM701 in Ovarian Cancer, MAIA Trial Preview, and UNIGEN Platform Advancements TranscriptOctober 5, 2026 | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: Dogwood Therapeutics (DWTX) and Compugen (CGEN)October 2, 2026 | theglobeandmail.comCompugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen™ Platform Update on October 5, 2026September 22, 2026 | prnewswire.comCompugen Shareholders Approve All Proposals at 2026 Annual MeetingSeptember 12, 2026 | theglobeandmail.comCompugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 8, 2026 | prnewswire.comCompugen (CGEN) Q2 2026 Earnings Call TranscriptAugust 11, 2026 | finance.yahoo.comCompugen: Better Runway Ahead Of MAIAAugust 7, 2026 | seekingalpha.comCompugen (CGEN) Q2 2026 EarningsAugust 3, 2026 | 247wallst.comCompugen Sets September 10, 2026 Annual Meeting, Details Board, Pay and Auditor VotesAugust 3, 2026 | tipranks.comCompugen Reports Second Quarter 2026 ResultsAugust 3, 2026 | prnewswire.comCompugen : CGENAugust 1, 2026 | 247wallst.comCompugen to Participate in BTIG Biotechnology Conference 2026July 21, 2026 | prnewswire.comCompugen to Release Second Quarter 2026 Results on Monday, August 3, 2026July 20, 2026 | prnewswire.comCompugen (CGEN) Stock Faces Mixed Analyst Target Changes After Cautious Valuation RevisionsJune 18, 2026 | finance.yahoo.comCompugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers CongressJune 18, 2026 | prnewswire.comCompugen Ltd. (CGEN) Discusses End-to-End AI-Driven Target Discovery in Immuno-Oncology TranscriptJune 15, 2026 | seekingalpha.comCompugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026June 11, 2026 | prnewswire.comCompugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug DevelopmentJune 8, 2026 | prnewswire.comH.C. Wainwright Keeps Their Buy Rating on Compugen (CGEN)June 6, 2026 | theglobeandmail.comWhy The Narrative Around Compugen (NasdaqCM:CGEN) Is Shifting After Analyst Resets And New ViewsJune 4, 2026 | finance.yahoo.comCompugen Ltd (CGEN) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesMay 26, 2026 | finance.yahoo.comCompugen: 'Buy' As Early Gastric Cancer Data Reinforces Rilvegostomig ProgramMay 20, 2026 | seekingalpha.comCompugen surges after revenue tops forecasts despite quarterly loss miss (CGEN)May 19, 2026 | msn.comCompugen Reports First Quarter 2026 ResultsMay 18, 2026 | prnewswire.comCompugen Q1 2026 earnings previewMay 17, 2026 | msn.comQuant snapshot: Baozun, Sohu among top-rated names as Sol Strategies, Arqit Quantum lagMay 17, 2026 | msn.comCompugen to Participate in 2026 Stifel Virtual Targeted Oncology ForumMay 12, 2026 | prnewswire.comCompugen to Release First Quarter 2026 Results on Monday, May 18, 2026May 4, 2026 | prnewswire.comCompugen (NASDAQ:CGEN) CEO Eran Ophir Sells 5,000 SharesApril 28, 2026 | insidertrades.comEran Ophir Sells 5,000 Shares of Compugen (NASDAQ:CGEN) StockApril 16, 2026 | insidertrades.comCompugen to Participate in 25th Annual Needham Virtual Healthcare ConferenceApril 9, 2026 | prnewswire.comLake Street initiates coverage of Compugen (CGEN) with buy recommendationApril 8, 2026 | msn.comCompugen (NASDAQ:CGEN) CEO Eran Ophir Sells 5,625 SharesApril 4, 2026 | insidertrades.comCompugen Ltd. (CGEN) Reports Q4 Revenue of $67.3 Million vs. $1.5 Million Last YearMarch 12, 2026 | insidermonkey.comCompugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...March 4, 2026 | finance.yahoo.comCompugen Ltd. (NASDAQ:CGEN) Q4 2025 Earnings Call TranscriptMarch 3, 2026 | insidermonkey.comCompugen (CGEN) Q4 2025 Earnings Call TranscriptMarch 2, 2026 | fool.comCompugen: Non-Dilutive Funding For Rilvegostomig Obtained And GS-0321 AdvancementMarch 2, 2026 | seekingalpha.comCompugen Reports Fourth Quarter and Full Year 2025 ResultsMarch 2, 2026 | prnewswire.comCompugen Ltd (CGEN) Q4 2025: Everything You Need To Know Ahead Of EarningsFebruary 27, 2026 | finance.yahoo.comCompugen to Participate in Upcoming Investor ConferencesFebruary 19, 2026 | prnewswire.comCompugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026February 17, 2026 | prnewswire.comCompugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of DirectorsFebruary 12, 2026 | prnewswire.com Compugen Media Mentions By Week Compugen Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGEN News Sentiment▼0.150.46▲Average Healthcare News Sentiment Compugen News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGEN Articles This Week▼23▲CGEN Articles Average Week Compugen Trends on MarketBeatThis week vs. last weekSearches1-50%Page Views1,578-14% Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Annexon News 4D Molecular Therapeutics News Sana Biotechnology News Prime Medicine News Lexicon Pharmaceuticals News Adlai Nortye News Design Therapeutics News Solid Biosciences News Pharming Group News Aura Biosciences News News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Compugen dated 10/18/2026. From Our PartnersWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the b...Porter & Company | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredThe $100 Stock Behind Elon's Next MoveA small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for mor...Paradigm Press | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compugen Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compugen With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
